Sotuletinib (dihydrochloride)
Sotuletinib (BLZ945) dihydrochloride is a potent, selective, orally active and brain-penetrant CSF-1R (c-Fms) inhibitor with an IC50 of 1 nM, showing more than 1,000-fold selectivity against its closest receptor tyrosine kinase homologs. Sotuletinib dihydrochloride can be used for microglia depletion, and for tumor and CNS-related disease research[1][2][3][4].
Product Specifications
CAS Number
2222138-40-9
Product Name Alternative
BLZ945 (dihydrochloride)
UNSPSC
12352005
Target
C-Fms
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/sotuletinib-dihydrochloride.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=NC=CC(OC2=CC=C3N=C(N[C@H]4[C@H](O)CCCC4)SC3=C2)=C1)NC.[H]Cl.[H]Cl
Molecular Formula
C20H24Cl2N4O3S
Molecular Weight
471.40
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 2
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Recombinant Vibrio cholerae serotype O1 Hemolysin (hlyA), partial
Mouse Monoclonal BRAF35 Antibody (PCRP-HMG20B-1B5) [mFluor Violet 450 SE]
NME2 (Non-Metastatic Cells 2, Protein (NM23B) Expressed in, MGC111212, NDPK-B, NDPKB, NM23-H2, NM23B, puf)